SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-078229
Filing Date
2020-06-29
Accepted
2020-06-29 20:11:58
Documents
1
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3866
  Complete submission text file 0001104659-20-078229.txt   5276
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1000 WINTER STREET SUITE 3300 WALTHAM MA 02451
Business Address
Alleva Lawrence M (Reporting) CIK: 0001553053 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38129 | Film No.: 20999424